These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lack of nidogen-2 increases blood pressure, glomerular and tubulointerstitial damage in DOCA-salt hypertension. Amann K, Haas CS, Zeiler GA, Benz K, Bader BL, Hartner A, Hilgers KF. Eur J Clin Invest; 2009 Feb; 39(2):116-25. PubMed ID: 19200165 [Abstract] [Full Text] [Related]
5. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Eur J Pharmacol; 2006 Dec 15; 552(1-3):131-4. PubMed ID: 17064681 [Abstract] [Full Text] [Related]
13. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kirchhoff F, Krebs C, Abdulhag UN, Meyer-Schwesinger C, Maas R, Helmchen U, Hilgers KF, Wolf G, Stahl RA, Wenzel U. Kidney Int; 2008 Mar 15; 73(5):643-50. PubMed ID: 18033241 [Abstract] [Full Text] [Related]
14. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension. Wang Y, Zhu M, Xu H, Cui L, Liu W, Wang X, Shen S, Wang DH. Exp Biol Med (Maywood); 2015 Sep 15; 240(9):1223-34. PubMed ID: 25585624 [Abstract] [Full Text] [Related]